|Brand||PlexBio Co., Ltd.|
Preeclampsia is a pregnancy-associated condition affecting the placenta in 6-8% of all pregnant women worldwide and is the major cause of prenatal birth, growth restriction of the fetus, and even maternal and fetal mortality in some cases.
PlexBio's IntelliPlexTM Preeclampsia Kit is designed to address the unmet need of preeclampsia diagnosis, leading to earlier disease detection, optimal patient treatment, and greater health economics. Target biomarkers including PAPP-A, AFP, PP13, sFlt-1, and sENG.
No Feedbacks yet.